BioInformGenomeWeb News Premium ContentExisting subscribers loginhere Newto BioInform

BioInformGenomeWeb News Premium ContentExisting subscribers loginhere Newto BioInform

Volume Number In PrintBioinformatics ToolRelated Papers of Note, Bioinformatics BriefsAccelrys, Becton Dickinson, Helicos, Translational Genomics Research Institute, Arizona State University, Obsidian Strategics, Microsystems, IDBS, PharmaLegacy Laboratories Downloads & UpgradesTIBCO Spotfire Lead Discovery, NextGENe, Corona Lite, Velvet, Condensation Tool People in the NewsJoel Saltz.

Minnesota Beefs Up IT Infrastructure for NextGen Sequencing at of Minnesota, Mayo project to complete computational infrastructure and workflow for secondgeneration sequencing, analysis, and data management is one of several ventures funded by the Minnesota Partnership for Biotechnology and Medical Genomics. Expression ProfileGenoLogics CEO Discusses Pfizer, Illumina Deals, Challenges of Research InformaticsGenoLogics CEO Michael Ball spoke to BioInform about the companys recent agreements with Pfizer and Illumina, which underscore the firms roots in research informatics despite its recent steps to expand into the translational informatics software market.

Minnesota Beefs Up IT Infrastructure for NextGen Sequencing at of Minnesota, Mayo project to complete computational infrastructure and workflow for secondgeneration sequencing, analysis, and data management is one of several ventures funded by the Minnesota Partnership for Biotechnology and Medical Genomics.

BioInformGenomeWeb News Premium ContentExisting subscribers loginhere. Newto BioInform? For trial subscription click here. Expression ProfileGenoLogics CEO Discusses Pfizer, Illumina Deals, Challenges of Research InformaticsGenoLogics CEO Michael Ball spoke to BioInform about the companys recent agreements with Pfizer and Illumina, which underscore the firms roots in research informatics despite its recent steps to expand into the translational informatics software market.

BioInformGenomeWeb News Premium ContentExisting subscribers loginhere. Newto BioInform? For trial subscription click here.

Expression ProfileGenoLogics CEO Discusses Pfizer, Illumina Deals, Challenges of Research InformaticsGenoLogics CEO Michael Ball spoke to BioInform about the companys recent agreements with Pfizer and Illumina, which underscore the firms roots in research informatics despite its recent steps to expand into the translational informatics software market. BioInformGenomeWeb News Premium ContentExisting subscribers loginhere. Newto BioInform? For trial subscription click here.

14, Subscriber LoginSubscribe to BioInformSite LicensesRSS FeedArchives In This Weeks IssueRx Postmortem Pfizer, Canadian Team to See If PGx Could Have Saved TorcetrapibOptimistic About PGx, Lilly Taps Cabernet Pharma to Develop Targeted Rx StrategyNanosphere Says Test Menu Must Expand Before Product Revenues Can AccelerateOIVDs Steven Gutman Leaving FDA for Academia No Replacement AnnouncedAffymetrix, Panomics, Clinical Data, Decode Genetics, CombiMatrixPGxHealthScott Milsten, Allen Lamb FeaturesEyeing New Market, JMP Partners with NCGR To Tweak Array Software for mRNA SequencingNCGR and JMP began collaborating several years on project to analyze array data, but as NCGR has moved more aggressively into sequencing, it drew JMP
Tags: , ,

Leave a Reply